Clinical Trials on Glabellar Crease in Ireland
Total 454 results
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States, Spain, Israel, United Kingdom, Italy, Poland, France, Brazil, Hungary, Germany, Argentina, Australia, Belgium, Luxembourg, South Korea, Czechia, Turkey (Türkiye)
-
NSABP Foundation IncNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials GroupActive, not recruitingStage II Breast Cancer | Stage IIIA Breast CancerUnited States, Canada, Puerto Rico
-
Stemline Therapeutics, Inc.CompletedBreast CancerUnited States, Spain, Israel, Italy, Australia, United Kingdom, Hungary, France, Belgium, Ireland, Portugal, Argentina, Canada, Denmark, Greece, Austria, South Korea
-
Puma Biotechnology, Inc.CompletedEarly Stage HER2+ Breast CancerSpain, United States, France, Australia, Germany, Austria, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Seagen Inc.Active, not recruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditionsUnited States, Canada, Puerto Rico
-
University of NebraskaNational Cancer Institute (NCI)CompletedBreast Cancer | Precancerous ConditionUnited States
-
Hoffmann-La RocheCompletedBreast CancerItaly, Belgium, Canada, United Kingdom, Argentina, Australia, Austria, Brazil, Bulgaria, China, Croatia, Denmark, Dominican Republic, Ecuador, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Indonesia, Irelan... and more
-
Institute of Cancer Research, United KingdomActive, not recruiting
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Canada, Italy, United Kingdom, Austria, Taiwan, Australia, Germany, Belgium, Spain, China, France, Brazil, Argentina, Hungary, Poland, Ireland, Romania, South Korea, Russia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
Novartis PharmaceuticalsNCIC Clinical Trials GroupCompletedBreast CancerUnited States, Belgium, Canada, United Kingdom, Argentina, Australia, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Taiwan, Thailand, India, Korea, Republic of, Mexico, Ukraine
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian...TerminatedNode Positive HER2 Negative Breast CancerUnited States, Canada, Puerto Rico, Guam
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.Active, not recruitingTriple Negative Breast CancerUnited States, Canada
-
AstraZenecaTerminatedBreast CancerUnited States, Italy, Spain, Canada, Switzerland, United Kingdom, Israel, Brazil, Austria
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
PfizerAstraZenecaCompletedMetastatic Breast CancerKorea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
BayerTerminatedBreast NeoplasmsSpain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
-
BayerOnyx Therapeutics, Inc.CompletedBreast CancerSpain, Ireland, Japan, Russian Federation, United States, Australia, Austria, Czechia, Belgium, China, Germany, Hungary, Israel, South Africa, United Kingdom, France, Greece, Puerto Rico, Italy, Canada, Poland, Sweden, Argentina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBreast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States, Puerto Rico
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingBreast CancerUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedAdvanced, Metastatic Breast CancerUnited States, Italy, Spain, Hungary, Taiwan, Belgium, Germany, Netherlands, Austria, Czechia, Australia, Canada, Israel, Russian Federation, United Kingdom, Korea, Republic of, Thailand, Lebanon, Denmark, France, Argentina, Sweden, Finlan... and more
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsCompleted
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Gilead SciencesCompletedBreast CancerUnited States, Canada, Spain, France, Belgium, United Kingdom, Germany
-
Merck Sharp & Dohme LLCRecruitingTriple-Negative Breast CancerUnited States, Israel, Australia, Malaysia, Spain, Norway, Argentina, Belgium, Germany, Portugal, Finland, Hong Kong, Italy, Canada, Czechia, Switzerland, France, Ireland, United Kingdom, Singapore, Japan, Austria, Brazil, Greece, Mexico, Polan... and more
-
Novartis PharmaceuticalsRecruitingEarly Breast CancerChina, United States, Canada, Germany, Taiwan, Israel, Portugal, Hong Kong, Argentina, Australia, India, South Korea, Brazil, Turkey (Türkiye), Mexico, Puerto Rico
-
Incyte CorporationTerminatedBreast CancerUnited States, France, United Kingdom, Spain, Italy, Portugal
-
SanofiCompleted
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsTerminatedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, China, Germany, Japan, Brazil, Mexico, Romania, Switzerland, Ukraine and more
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NSABP Foundation IncCompletedBreast Cancer | Perioperative/Postoperative ComplicationsUnited States, Canada
-
R-PharmTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
NSABP Foundation IncNational Cancer Institute (NCI); Eli Lilly and Company; AstraZenecaCompletedStudy of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenBreast CancerUnited States, Canada, Puerto Rico
-
Seagen, a wholly owned subsidiary of PfizerRemeGen Co., Ltd.RecruitingStomach Neoplasms | Breast Neoplasms | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Neoplasms | Metastatic Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Cancer | HER2 Positive Breast Neoplasms | HER2 Low Breast NeoplasmsUnited States, United Kingdom, Spain, Canada, Taiwan, Germany, Australia, Japan, Italy, South Korea
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
PfizerInternational Collaborative Cancer GroupCompletedBreast NeoplasmsAustralia, Denmark, Netherlands, United States, Bulgaria, Hungary, Italy, Spain, Belgium, Czech Republic, Ireland, Poland, Russian Federation, Sweden, United Kingdom, Croatia, Serbia, Germany, Bosnia and Herzegovina, Norway, South... and more
-
Canadian Cancer Trials GroupAlliance for Clinical Trials in Oncology; NRG Oncology; Eastern Cooperative Oncology... and other collaboratorsRecruitingBreast CancerUnited States, Canada